113 related articles for article (PubMed ID: 38102728)
1. NRIP1 regulates cell proliferation in lung adenocarcinoma cells.
Watanabe F; Sato S; Hirose T; Endo M; Endo A; Ito H; Ohba K; Mori T; Takahashi K
J Biochem; 2024 Mar; 175(3):323-333. PubMed ID: 38102728
[TBL] [Abstract][Full Text] [Related]
2. Expression and role of nuclear receptor-interacting protein 1 (NRIP1) in stomach adenocarcinoma.
Fang D; Lu G
Ann Transl Med; 2020 Oct; 8(20):1293. PubMed ID: 33209873
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
[TBL] [Abstract][Full Text] [Related]
4. NRIP1 aggravates lung injury caused by
Huang M; Li J; Bai J; Du X; Guo H; Wang B; Xu J
Aging (Albany NY); 2022 Apr; 14(8):3529-3539. PubMed ID: 35460552
[TBL] [Abstract][Full Text] [Related]
5. Suppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo.
Aziz MH; Chen X; Zhang Q; DeFrain C; Osland J; Luo Y; Shi X; Yuan R
Oncotarget; 2015 Nov; 6(37):39714-24. PubMed ID: 26492163
[TBL] [Abstract][Full Text] [Related]
6. A Dominant Mutation in Nuclear Receptor Interacting Protein 1 Causes Urinary Tract Malformations
Vivante A; Mann N; Yonath H; Weiss AC; Getwan M; Kaminski MM; Bohnenpoll T; Teyssier C; Chen J; Shril S; van der Ven AT; Ityel H; Schmidt JM; Widmeier E; Bauer SB; Sanna-Cherchi S; Gharavi AG; Lu W; Magen D; Shukrun R; Lifton RP; Tasic V; Stanescu HC; Cavaillès V; Kleta R; Anikster Y; Dekel B; Kispert A; Lienkamp SS; Hildebrandt F
J Am Soc Nephrol; 2017 Aug; 28(8):2364-2376. PubMed ID: 28381549
[TBL] [Abstract][Full Text] [Related]
7. A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors.
Palassin P; Lapierre M; Pyrdziak S; Wagner A; Stehle R; Corsini C; Duffour J; Bonnet S; Boulahtouf A; Rodriguez C; Ho-Pun-Cheung A; Lopez-Crapez E; Boissière-Michot F; Bibeau F; Thezenas S; Elarouci N; Selves J; Hoffmann JS; Roepman P; Mazard T; Buhard O; Duval A; Jalaguier S; Cavaillès V; Castet-Nicolas A
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503257
[TBL] [Abstract][Full Text] [Related]
8. Tumor Promoting Role of NRIP1 in Oral Squamous Cell Carcinoma: The Involvement of NSD2-Mediated Histone Methylation of DGCR8.
Zhang L; Hu G
Tohoku J Exp Med; 2023 Jul; 260(3):193-204. PubMed ID: 37045786
[TBL] [Abstract][Full Text] [Related]
9. Thyroid transcription factor 1 represses the expression of Ki-67 and induces apoptosis in non-small cell lung cancer.
Zu YF; Wang XC; Chen Y; Wang JY; Liu X; Li X; Li CW; Xie YC; Luo Y; Shang XQ; Guo J
Oncol Rep; 2012 Nov; 28(5):1544-50. PubMed ID: 22940844
[TBL] [Abstract][Full Text] [Related]
10. The Expression of NRIP1 and LCOR in Endometrioid Endometrial Cancer.
Flindris S; Katsoulas N; Goussia A; Lazaris AC; Navrozoglou I; Paschopoulos M; Thymara I
In Vivo; 2021; 35(5):2631-2640. PubMed ID: 34410950
[TBL] [Abstract][Full Text] [Related]
11. MiR-499 enhances
Wang C; Li X
J Biosci; 2023; 48():. PubMed ID: 38047488
[TBL] [Abstract][Full Text] [Related]
12. Rac3 regulates cell proliferation through cell cycle pathway and predicts prognosis in lung adenocarcinoma.
Wang G; Wang H; Zhang C; Liu T; Li Q; Lin X; Xie J; Liu H
Tumour Biol; 2016 Sep; 37(9):12597-12607. PubMed ID: 27402308
[TBL] [Abstract][Full Text] [Related]
13. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
[TBL] [Abstract][Full Text] [Related]
14.
Sun ZQ; Chen G; Guo Q; Li HF; Wang Z
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061179
[TBL] [Abstract][Full Text] [Related]
15. MID1-PP2A complex functions as new insights in human lung adenocarcinoma.
Zhang L; Li J; Lv X; Guo T; Li W; Zhang J
J Cancer Res Clin Oncol; 2018 May; 144(5):855-864. PubMed ID: 29450633
[TBL] [Abstract][Full Text] [Related]
16. TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG.
Wang J; Pan X; Li J; Zhao J
Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35485284
[TBL] [Abstract][Full Text] [Related]
17. Circ_0000011 promotes cerebral ischemia/reperfusion injury via miR-27a-3p-dependent regulation of NRIP1.
Ren X; Zhou X
Metab Brain Dis; 2023 Jan; 38(1):295-306. PubMed ID: 35925446
[TBL] [Abstract][Full Text] [Related]
18. miR‑888 regulates cancer progression by targeting multiple targets in lung adenocarcinoma.
Cao JX
Oncol Rep; 2019 Jun; 41(6):3367-3376. PubMed ID: 31002360
[TBL] [Abstract][Full Text] [Related]
19. Deletion of Nrip1 delays skin aging by reducing adipose-derived mesenchymal stem cells (ADMSCs) senescence, and maintaining ADMSCs quiescence.
Hu Y; Zhu Y; Gerber SD; Osland JM; Chen M; Rao KA; Gu H; Yuan R
Geroscience; 2021 Aug; 43(4):1815-1833. PubMed ID: 33704619
[TBL] [Abstract][Full Text] [Related]
20. UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma.
Yao J; Reyimu A; Sun A; Duoji Z; Zhou W; Liang S; Hu S; Wang X; Dai J; Xu X
World J Surg Oncol; 2022 May; 20(1):153. PubMed ID: 35546675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
